Drug · DIN 02457431
ERFA-TRANEXAMIC
SINGLE-USE VIAL
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 18, 2024; first marketed July 31, 2017.
- Drug Identification Number (DIN)
- 02457431
- Company (DIN owner)
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Tranexamic acid B02AA02
- Class
- Human
- Record last updated
- August 7, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TRANEXAMIC ACID | 100 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 19, 2022: NOC 29253New Drug Submission (NDS) · Administrative: Change in Product Ownership
- September 6, 2016: NOC 18450Abbreviated New Drug Submission (ANDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “erfa-tranexamic”. A notice may cover another product or only some lots: read it to see what it covers.
- Erfa-Tranexamic 100 mg/mL (5 ml)May 3, 2018 · Drugs · Product safety · Type I
- Erfa-Tranexamic 100 mg/mL (50mL)April 25, 2018 · Drugs · Product safety · Type I